Adagio Medical seeks FDA PMA for ventricular ablation system

The application draws on data from the FULCRUM-VT pivotal IDE trial, which enrolled 209 patients across 20 centres.
MassDevice

Adagio submits ventricular ablation system to FDA

Adagio Medical (Nasdaq:ADGM) announced today that it submitted its premarket approval (PMA) application to the FDA for its ...

Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia

Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation ...
Yahoo Finance

First in Human Ischemic VT Ablation Successfully Performed in iCMR

The Amsterdam UMC team, shown here, performed the VT ablation procedure following previous experiences performing atrial flutter and premature ventricular complex (PVC) ablation procedures guided by ...
Healio

Catheter ablation superior to antiarrhythmic drugs in VT with ischemic cardiomyopathy

Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.
TCTMD

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...
MedPage Today

Impella Not Linked to Better VT Ablation Outcomes

NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
Healio

BERLIN-VT: Timing of ventricular tachycardia ablation does not affect mortality in patients with MI, ICD

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients with ventricular tachycardia indicated for an implantable cardioverter ...
Medscape

High rate of VT recurrence in ARVD/C patients undergoing catheter ablation

Baltimore, MD - A report published this week has shown a high rate of ventricular tachycardia (VT) recurrence—as high as 75% at 14 months—in arrhythmogenic right ventricular dysplasia/cardiomyopathy ...